IndraLab
Statements
reach
"XREF_FIG demonstrates that in the total cell lysate of virtually all the lymphoma cell lines with either wild-type (wt) or mutant p53, doxorubicin treatment increased p53 protein levels starting at 3h, and the increases were sustained at 6 and 24 h (the results from DoHH2, JOK-1, and DHL-4 cells are shown; anti-p53 antibody : FL393)."
reach
"As reviewed by Stiewe and Haran [16], cancer-associated mutations alter p53 in three ways: they promote the loss of wild-type (wt) p53 DNA binding, trigger dominant-negative inhibition of wtp53 by the mutant p53 in the monoallelic mutation setting, or induce the gain of new functions by mutant p53 through new protein–protein–DNA interactions."